- Home
- KNSA vs AYA Comparison
KNSA vs AYA Comparison
Compare KNSA & AYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$55.11
N/A
Current Price
$0.00
Company Overview
Basic Information| Metric | KNSA | AYA |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United Kingdom | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.0B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | KNSA | AYA |
|---|---|---|
| Price | $55.11 | N/A |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $60.86 | N/A |
| AVG Volume (30 Days) | ★ 492.0K | N/A |
| Earning Date | 04-28-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 225.00 | N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $677,564,000.00 | N/A |
| Revenue This Year | $37.48 | N/A |
| Revenue Next Year | $17.87 | N/A |
| P/E Ratio | $204.43 | ★ N/A |
| Revenue Growth | ★ 60.09 | N/A |
| 52 Week Low | $26.27 | N/A |
| 52 Week High | $59.87 | N/A |
Technical Indicators
Market Signals| Indicator | KNSA | AYA |
|---|---|---|
| Relative Strength Index (RSI) | 63.62 | N/A |
| Support Level | $40.67 | N/A |
| Resistance Level | $59.87 | N/A |
| Average True Range (ATR) | 1.83 | 0.00 |
| MACD | 0.59 | 0.00 |
| Stochastic Oscillator | 91.10 | 0.00 |
Price Performance
Historical Comparison KNSA
AYA
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.